News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
788,822 Results
Type
Article (64337)
Company Profile (641)
Press Release (723844)
Multimedia
Podcasts (104)
Webinars (14)
Section
Business (222837)
Career Advice (3176)
Deals (38244)
Drug Delivery (126)
Drug Development (87974)
Employer Resources (189)
FDA (17673)
Job Trends (16490)
News (378808)
Policy (37426)
Tag
Academia (2990)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (96)
Alliances (55185)
ALS (104)
Alzheimer's disease (1504)
Antibody-drug conjugate (ADC) (162)
Approvals (17632)
Artificial intelligence (304)
Autoimmune disease (29)
Automation (16)
Bankruptcy (394)
Best Places to Work (12531)
BIOSECURE Act (21)
Biosimilars (120)
Biotechnology (438)
Bladder cancer (85)
Brain cancer (30)
Breast cancer (311)
Cancer (2468)
Cardiovascular disease (206)
Career advice (2678)
Career pathing (34)
CAR-T (175)
Cell therapy (480)
Cervical cancer (22)
Clinical research (71101)
Collaboration (934)
Company closure (2)
Compensation (561)
Complete response letters (29)
COVID-19 (2864)
CRISPR (50)
C-suite (271)
Cystic fibrosis (109)
Data (2360)
Decentralized trials (2)
Denatured (37)
Depression (55)
Diabetes (302)
Diagnostics (6887)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (132)
Drug pricing (131)
Drug shortages (32)
Duchenne muscular dystrophy (104)
Earnings (92389)
Editorial (46)
Employer branding (24)
Employer resources (162)
Events (123892)
Executive appointments (784)
FDA (19097)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (822)
Gene editing (124)
Generative AI (26)
Gene therapy (354)
GLP-1 (850)
Government (5039)
Grass and pollen (6)
Guidances (150)
Healthcare (20737)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (145)
Indications (30)
Infectious disease (3027)
Inflammatory bowel disease (159)
Inflation Reduction Act (11)
Influenza (58)
Intellectual property (102)
Interviews (585)
IPO (17458)
IRA (50)
Job creations (4436)
Job search strategy (2223)
Kidney cancer (11)
Labor market (44)
Layoffs (548)
Leadership (24)
Legal (9307)
Liver cancer (82)
Lung cancer (349)
Lymphoma (161)
Machine learning (9)
Management (63)
Manufacturing (362)
MASH (80)
Medical device (14530)
Medtech (14535)
Mergers & acquisitions (21354)
Metabolic disorders (801)
Multiple sclerosis (89)
NASH (22)
Neurodegenerative disease (116)
Neuropsychiatric disorders (33)
Neuroscience (2115)
NextGen: Class of 2025 (7508)
Non-profit (5063)
Now hiring (41)
Obesity (432)
Opinion (271)
Ovarian cancer (83)
Pain (104)
Pancreatic cancer (91)
Parkinson's disease (163)
Partnered (23)
Patents (258)
Patient recruitment (119)
Peanut (51)
People (62669)
Pharmaceutical (132)
Pharmacy benefit managers (22)
Phase I (22075)
Phase II (31094)
Phase III (23389)
Pipeline (1395)
Policy (176)
Postmarket research (3010)
Preclinical (9761)
Press Release (72)
Prostate cancer (114)
Psychedelics (34)
Radiopharmaceuticals (268)
Rare diseases (434)
Real estate (6862)
Recruiting (73)
Regulatory (25433)
Reports (51)
Research institute (2643)
Resumes & cover letters (502)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (142)
Series B (94)
Service/supplier (28)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (161)
Sponsored (34)
Startups (4054)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (53)
The Weekly (65)
Vaccines (816)
Venture capitalists (44)
Weight loss (301)
Women's health (39)
Worklife (20)
Date
Today (176)
Last 7 days (986)
Last 30 days (3232)
Last 365 days (34787)
2025 (12392)
2024 (37662)
2023 (42400)
2022 (53746)
2021 (58498)
2020 (57431)
2019 (50977)
2018 (38762)
2017 (35760)
2016 (36017)
2015 (42009)
2014 (36186)
2013 (32036)
2012 (34333)
2011 (34577)
2010 (32901)
Location
Africa (1012)
Alabama (61)
Alaska (7)
Arizona (265)
Arkansas (14)
Asia (45474)
Australia (7785)
California (6663)
Canada (2104)
China (571)
Colorado (286)
Connecticut (300)
Delaware (166)
Europe (102848)
Florida (965)
Georgia (226)
Hawaii (1)
Idaho (63)
Illinois (619)
India (29)
Indiana (341)
Iowa (12)
Japan (176)
Kansas (113)
Kentucky (28)
Louisiana (14)
Maine (70)
Maryland (981)
Massachusetts (5072)
Michigan (248)
Minnesota (426)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (25)
Nevada (69)
New Hampshire (69)
New Jersey (1853)
New Mexico (31)
New York (1864)
North Carolina (1142)
North Dakota (9)
Northern California (2873)
Ohio (224)
Oklahoma (15)
Oregon (46)
Pennsylvania (1458)
Puerto Rico (14)
Rhode Island (36)
South America (1413)
South Carolina (26)
South Dakota (1)
Southern California (2473)
Tennessee (108)
Texas (995)
United States (25322)
Utah (199)
Virginia (174)
Washington D.C. (72)
Washington State (609)
West Virginia (3)
Wisconsin (70)
788,822 Results for "pro dex inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Pro-Dex, Inc. Announces Fiscal 2024 First Quarter Results
PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024 first quarter ended September 30, 2023.
November 2, 2023
·
6 min read
Press Releases
Pro-Dex, Inc. Announces Fiscal 2024 Fourth Quarter and Full-Year Results
September 6, 2024
·
9 min read
Business
Pro-Dex, Inc. Announces Fiscal 2023 Third Quarter and Nine-Month Results
PRO-DEX, INC. announced financial results for its fiscal 2023 third quarter ended March 31, 2023.
May 4, 2023
·
8 min read
Business
Pro-Dex, Inc. Announces Fiscal 2023 Second Quarter and Six-Month Results
PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2023 second quarter ended December 31, 2022.
February 2, 2023
·
6 min read
Earnings
Amgen Advocates For ‘Pro-Growth Tax Policy’ Instead of Tariffs to Boost Domestic Manufacturing
Like fellow Big Pharmas Eli Lilly and Johnson & Johnson, Amgen is urging the Trump administration to consider tax policy instead of tariffs to promote domestic pharma manufacturing.
May 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Nordic Bioscience announces PRO-C3 launched by Roche Diagnostics on cobas analysers
May 8, 2025
·
2 min read
Press Releases
AtriCure Announces First Use of the AtriClip PRO-Mini® Device
April 10, 2025
·
5 min read
Press Releases
Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application
April 29, 2025
·
3 min read
Press Releases
Roche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity
May 6, 2025
·
5 min read
Policy
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Co-Diagnostics, Inc. announced that the Company has completed its first U.S. Food and Drug Administration application for 510 clearance for the Co-Dx™ PCR Pro™ instrument, and the Co-Dx PCR COVID-19 Test for over-the-counter use.
June 14, 2024
·
4 min read
1 of 78,883
Next
